Clinical Trial Update: Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D) [NA]

View source ↗

Summary

This clinical trial update describes the implementation of the Spotlight AQ Platform in adolescents and young adults aged 16-25 with Type 1 Diabetes Mellitus. R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Type 1 Diabetes Mellitus | NA | Status: RECRUITING